Category: Advances in Hepatology
Fibroscan (Transient Elastography) for the Measurement of Liver Fibrosis
Advances in Hepatology Fibroscan (Transient Elastography) for the Measurement of Liver Fibrosis Nezam H. Afdhal, MD Director of Hepatology Beth Israel Deaconess Medical Center Professor of […]
Risk of Autoimmune Complications Associated with Interferon Therapy
Marcelo O. Silva, MD Head of Hepatology and Liver Transplant Unit Austral University Hospital Buenos Aires, Argentina G&H Which autoimmune conditions have been observed in hepatitis […]
Management of Patients Who Are Not Candidates for Protease Inhibitor Therapy
Paul J. Pockros, MD Head of the Division of Gastroenterology and Hepatology Director of the Center for Liver Diseases Scripps Clinic Director of Clinical Research Scripps […]
Screening for Hepatitis C Virus Infection
Paul Y. Kwo, MD Associate Professor of Medicine Medical Director of Liver Transplantation Division of Gastroenterology and Hepatology Indiana University School of Medicine Indianapolis, Indiana G&H […]
The Adaptive Response (Drug Tolerance) Helps to Prevent Drug-Induced Liver Injury
James H. Lewis, MD Professor and Director of Hepatology Division of Gastroenterology Department of Medicine Georgetown University Hospital Washington, DC G&H How frequently do drugs cause […]
Management of Anemia in Patients Receiving Protease Inhibitors
Stephen A. Harrison, MD, LTC, MC Chief of Hepatology Brooke Army Medical Center Clinical Associate Professor of Medicine University of Texas Health Science Center at San […]
Use of Protease Inhibitors in Liver Transplant Recipients
Gary L. Davis, MD, and Jacqueline G. O’Leary, MD Liver Consultants of Texas Baylor University Medical Center and Simmons Transplant Institute Dallas, Texas G&H What is […]
Vaccinating Patients with Chronic Liver Disease
Miriam J. Alter, PhD Professor, Department of Internal Medicine Division of Infectious Diseases University of Texas Medical Branch Galveston, Texas G&H What is the benefit of […]
Management of Hepatitis C Virus Infection in Liver Transplant Recipients
Satheesh P. Nair, MD Professor of Medicine Director of Transplant Hepatology Methodist University Hospital University of Tennessee Health Science Center Memphis, Tennessee G&H How common is […]
The Role of Serum Biomarkers in Hepatocellular Carcinoma Surveillance
Jorge A. Marrero, MD, MS Keith S. Henley Collegiate Professor of Gastroenterology Director, Multidisciplinary Liver Tumor Clinic University of Michigan Ann Arbor, Michigan G&H Why would […]
Hepatitis E Virus Infection: More Common Than Previously Realized?
Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director of the Division of Digestive Diseases University of Cincinnati College of Medicine Cincinnati, Ohio G&H In […]
Use of Imaging Studies to Aid in the Diagnosis of Benign Liver Tumors
Beatrice L. Madrazo, MD, FACR Associate Professor of Clinical Radiology Director of Radiology Research Miller School of Medicine University of Miami Miami, Florida G&H What types […]
Management of Pruritus in Patients with Cholestatic Liver Disease
Cynthia Levy, MD Associate Professor of Medicine Center for Liver Diseases University of Miami Miami, Florida G&H How frequently does pruritus occur in patients with cholestatic liver […]
Utility of IL-28B Polymorphisms in the Era of Direct-Acting Antiviral Therapy
Stuart C. Gordon, MD Director of Hepatology Henry Ford Health System Clinical Professor of Medicine Wayne State University School of Medicine Detroit, Michigan G&H Why is interleukin-28B […]
Diagnosis and Management of Telaprevir-Associated Rash
Eric J. Lawitz, MD, CPI President and Medical Director Alamo Medical Research San Antonio, Texas G&H How common is rash among patients treated with telaprevir? EL The safety […]
Genome-Wide Association Studies: “SNPing” Away at Liver Disease
Emmanuel Thomas, MD, PhD Liver Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda, Maryland G&H How are genome-wide association studies […]
Irreversible Electroporation for Treatment of Liver Cancer
Govindarajan Narayanan, MD Chief of Vascular and Interventional Radiology Miller School of Medicine University of Miami Miami, Florida G&H How does the NanoKnife work? GN The NanoKnife (AngioDynamics) […]
Immunoglobulin G4-Associated Autoimmune Cholangiopathy
Keith D. Lindor, MD Department of Gastroenterology and Hepatology Mayo Clinic Rochester, Minnesota G&H What is the typical presentation of immunoglobulin G4-associated autoimmune cholangiopathy? Does this condition […]
Exploring the Possibility of an Interferon-Free Treatment Regimen for Hepatitis C Virus Infection
Mark Sulkowski, MD Associate Professor of Medicine Medical Director, Viral Hepatitis Center Johns Hopkins University School of Medicine Baltimore, Maryland G&H What are the disadvantages of interferon-based […]
Current Status of Alpha-Fetoprotein Testing
Morris Sherman, MD, PhD Associate Professor of Medicine University of Toronto Toronto, Ontario G&H Is alpha-fetoprotein testing useful for diagnosing and/or monitoring hepatocellular carcinoma? MS Alpha-fetoprotein (AFP) testing […]